Children with these disorders might have difficulty clearing bisphenol A (BPA) from their bodies, leading to prolonged exposure, according to the study.
As of August 2023, the U.S. is still experiencing a shortage of several ADHD medications, with some not expected to be resolved for at least a few more months.